Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
22 drugs in development
By Therapeutic Area
top 6
R&D Momentum
87/100
Pipeline Velocity
65/100
Trial Completion Rate
75/100
Pipeline Concentration
18/100
Pipeline Freshness
71/100
Strategic Signals
Activity
Last 14 days
Influence of Biological Sex and Age on Cerebral Blood Flow and Vessel Function During Exercise: a Pilot Study
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy (COCO-GA) Protocol
Elucidating Factors Contributing to Dysphagia in Frail Older Adults
Enhance the Restorative Power of Sleep Through TES-TI Power Naps
Using a Pragmatic Randomized Rollout Trial to Evaluate Implementation Strategies to Promote Smoking Treatment and Cancer Prevention for Salvation Army Clients
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
Genetic and MRI Biomarkers of Neuroplasticity Predict Aphasia Recovery and Phenotypes
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors (DANE)
The Impact of Cerebral Anatomical Variations on Cerebrovascular Reactivity
Human Cerebral Blood Flow Regulation: Sex, Mechanism, and Stress Differences
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)